These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30289584)

  • 21. Challenges of implementation: Strategic purchasing in Iran Health Insurance Organization.
    Kalantari AR; Jafari Sirizi M; Mehrolhassani MH; Dehnavieh R
    Int J Health Plann Manage; 2019 Jan; 34(1):e875-e884. PubMed ID: 30408235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relevance of socioeconomic and health policy issues to clinical research. The case of MRI and neuroradiology.
    Larson EB; Kent DL
    Int J Technol Assess Health Care; 1989; 5(2):195-206. PubMed ID: 10303486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT IN IRAN.
    Mohtasham F; Majdzadeh R; Jamshidi E
    Int J Technol Assess Health Care; 2017 Jan; 33(4):529-533. PubMed ID: 28814351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the Challenges and Opportunities in Home Care to Facilitate Effective Information Technology Adoption.
    Koru G; Alhuwail D; Topaz M; Norcio AF; Mills ME
    J Am Med Dir Assoc; 2016 Jan; 17(1):53-8. PubMed ID: 26612483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of global budget on the diffusion of innovations: the example of positron emission tomography in Taiwan.
    Yang CM
    BMC Health Serv Res; 2018 Nov; 18(1):905. PubMed ID: 30486808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion of new technologies: rational and irrational.
    Perry S
    J Health Care Technol; 1984; 1(2):73-88. PubMed ID: 10271139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of the diffusion of computed tomography and magnetic resonance imaging.
    Oh EH; Imanaka Y; Evans E
    Int J Technol Assess Health Care; 2005; 21(1):73-80. PubMed ID: 15736517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion of diagnostic medical devices and policy implications for India.
    Mahal A; Varshney A; Taman S
    Int J Technol Assess Health Care; 2006; 22(2):184-90. PubMed ID: 16571194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managers' experience of success criteria and barriers to implementing mobile radiography services in nursing homes in Norway: a qualitative study.
    Kjelle E; Lysdahl KB; Olerud HM; Myklebust AM
    BMC Health Serv Res; 2018 Apr; 18(1):301. PubMed ID: 29699547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health system organizational reform in governing Iranian public hospitals: A content analysis to comprehend the barriers in Board of Trustees' hospitals.
    Jafari M; Habibirad A; Pourtaleb A; Salarianzadeh MH
    Int J Health Plann Manage; 2018 Apr; 33(2):e612-e620. PubMed ID: 29573461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital adoption of medical technology: an empirical test of alternative models.
    Teplensky JD; Pauly MV; Kimberly JR; Hillman AL; Schwartz JS
    Health Serv Res; 1995 Aug; 30(3):437-65. PubMed ID: 7649751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact assessment of Iran's health technology assessment programme.
    Yazdizadeh B; Mohtasham F; Velayati A
    Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-health implementation challenges in Iranian medical centers: a qualitative study in Iran.
    Sharifi M; Ayat M; Jahanbakhsh M; Tavakoli N; Mokhtari H; Wan Ismail WK
    Telemed J E Health; 2013 Feb; 19(2):122-8. PubMed ID: 23374035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical technology and inequity in health care: the case of Korea.
    Yang BM
    Health Policy Plan; 1993 Dec; 8(4):385-93. PubMed ID: 10131034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explaining the adoption and use of computed tomography and magnetic resonance image technologies in public hospitals.
    Reyes-Santias F; Antelo M
    BMC Health Serv Res; 2021 Nov; 21(1):1278. PubMed ID: 34838015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between HMO market share and the diffusion and use of advanced MRI technologies.
    Baker LC; Atlas SW
    J Am Coll Radiol; 2004 Jul; 1(7):478-87. PubMed ID: 17411636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How is magnetic resonance imaging used in Iran?
    Palesh M; Fredrikson S; Jamshidi H; Tomson G; Petzold M
    Int J Technol Assess Health Care; 2008; 24(4):452-8. PubMed ID: 18828940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diffusion of magnetic resonance imaging scanners in a changing U.S. health care environment.
    Hillman BD; Neu CR; Winkler JD; Aroesty J; Rettig RA; Williams AP
    Int J Technol Assess Health Care; 1987; 3(4):545-59. PubMed ID: 10285723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.